Subscribe to receive the most important news
“It is time to start using all medical weapons to fight cancer.” With these words, Dr. Amr Shafiq, professor of oncology at Ain Shams University, described how to deal with the disease in the future, and revealed what is called “personalized treatment” or comprehensive genetic analysis of tumors, as a start For a new era of modern methods that lead to a broader knowledge of the disease for each individual patient, leading to the allocation of appropriate treatment for each patient.
Shafiq said that “personalized treatment” is a detailed treatment for each patient individually through its own genetic analysis, noting that personalized health care works by collecting and analyzing patient data and comparing it with data from other patients who suffer from the same disease, and the differences that characterize it Each person provides a deeper understanding of this disease, and provides information about how the patient responds to treatment, which helps in making appropriate options for a successful treatment.
Al-Masry Al-Youm attended the first meeting of its kind in the Middle East for the Health Care Forum, in the presence of professors of oncology, genetics experts, and civil society organizations concerned with patients, who discussed “personalized” health care and development in precision medicine and genetics, and the participants shed light on the role it plays Genetics in cancer treatment and technological advances in accelerating the development of precision medicine.
Participants explained the “personalized” health care mechanism that works by collecting and analyzing patient data and comparing it with data from other patients who suffer from the same disease. The differences that characterize each person show a deeper understanding of this disease and provide information about how the patient responds to treatment, which helps in To take appropriate options for a successful treatment, and a set of studies showing the clinical application of genetics and advanced solutions was presented with the aim of achieving better results in the cancer treatment process.
Dr. Amr Shafiq, Professor of Oncology at Ain Shams University, stressed that the comprehensive genetic analysis of tumors is the beginning of a new era of modern methods that leads to a wider knowledge of the disease for each individual patient, which leads to the allocation of appropriate treatment for each patient, especially that the American Medicines Organization has adopted more Of the 700 oncology drugs, therefore one treatment must be determined for each individual patient.
Shafiq told Al-Masry Al-Youm: “The difference between personalized and conventional treatment is large. If we assume that we have a hundred patients with lung cancer, they are all treated with conventional“ chemical ”treatment, we find that only 20% of them respond to treatment and 80% do not respond to treatment and are exposed to bad side effects, Therefore, we find many patients hate chemotherapy, and after the emergence of gene therapy, the diagnosis is made for each individual case according to the genetic information and the changes related to the cancerous cell and provide detailed treatment for this patient.
During the panel discussion, Dr. Salah Abbasi, consultant of oncology and hematology at the Al-Khaldi Medical Complex in Amman, indicated that accurate medicine is the art of allocating health care to each patient based on his or her specific needs and relying on his histological and genetic information and his health conditions.
He stressed the need for the patient to be the main partner in choosing this type of treatment convincedly so that he can complete the journey to its end, indicating that there are 140 types of targeted therapy that specifically attack cancer cells and the doctor’s role choosing the right type for the patient’s condition.
And Dr. Ramy Mahfouz, Head of the Pathology Department at the American University of Beirut Medical Center, considered that personal medicine through genetic testing will become a distinctive feature of the next generation as patients will be able to use the latest technologies and artificial intelligence that allows them to cross borders and obtain various Reviews and treatment options from around the world.